Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AG-SILODOSIN DIN 02541335

Status: Approved
Holder: ANGITA PHARMA INC.
Molecule: SILODOSIN

Health Canada record

Active ingredient(s)SILODOSIN 8 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCG04CA04 SILODOSIN
Original market date
Current status date11-Sep-2023
SourceHealth Canada DPD

Establishment licence of the holder

Angita Pharma Inc. — licence 101870, currently licensed, last inspection rating C (2025-01-13).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing SILODOSIN

DINProductCompanyFormStrengthStatus
02541327AG-SILODOSINANGITA PHARMA INC.CapsuleSILODOSIN 4 MGApproved
02479850APO-SILODOSINAPOTEX INCCapsuleSILODOSIN 4 MGApproved
02478501AURO-SILODOSINAURO PHARMA INCCapsuleSILODOSIN 4 MGMarketed
02478528AURO-SILODOSINAURO PHARMA INCCapsuleSILODOSIN 8 MGMarketed
02539519JAMP SILODOSINJAMP PHARMA CORPORATIONCapsuleSILODOSIN 4 MGMarketed
02539527JAMP SILODOSINJAMP PHARMA CORPORATIONCapsuleSILODOSIN 8 MGMarketed
02517779PMS-SILODOSINPHARMASCIENCE INCCapsuleSILODOSIN 4 MGMarketed
02517787PMS-SILODOSINPHARMASCIENCE INCCapsuleSILODOSIN 8 MGMarketed
02475421SANDOZ SILODOSINSANDOZ CANADA INCORPORATEDCapsuleSILODOSIN 4 MGMarketed
02475448SANDOZ SILODOSINSANDOZ CANADA INCORPORATEDCapsuleSILODOSIN 8 MGMarketed
02565986SILODOSINSANIS HEALTH INCCapsuleSILODOSIN 8 MGApproved
02565978SILODOSINSANIS HEALTH INCCapsuleSILODOSIN 4 MGApproved
02361663RAPAFLOALLERGAN INCCapsuleSILODOSIN 4 MGCancelled Post Market
02361671RAPAFLOALLERGAN INCCapsuleSILODOSIN 8 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
315952023-09-12Abbreviated New Drug Submission (ANDS)Administrative: Licensing Agreement Between Two Manufacturers

International API supply for SILODOSIN

18 active FDA Drug Master Files.

Request a quote for AG-SILODOSIN

How to read a Canadian DIN record